📌 Introduction: Why Gastric Medicine is a Top-Selling Category in Bangladesh
Gastric problems such as acidity, GERD (Gastroesophageal Reflux Disease), peptic ulcer, and dyspepsia are among the most common health complaints in Bangladesh. Due to dietary habits, stress, irregular eating patterns, and widespread use of NSAIDs, the demand for gastric medicines has grown significantly.
The Proton Pump Inhibitor (PPI) class dominates this segment due to its superior acid suppression and clinical effectiveness.
According to global and regional pharmaceutical insights:
- PPIs account for the largest share of gastrointestinal drug sales
- Bangladesh PPI market is growing steadily year-on-year
- Esomeprazole-based brands dominate prescriptions
🔗 Reference:
- https://www.6wresearch.com/industry-report/bangladesh-proton-pump-inhibitors-market
- https://medex.com.bd/drug-classes/529/proton-pump-inhibitor
🧪 What Are Gastric Medicines? (PPI Overview)
Gastric medicines mainly belong to:
🔬 Proton Pump Inhibitors (PPIs)
- Esomeprazole
- Omeprazole
- Pantoprazole
- Rabeprazole
💡 Mechanism of Action
PPIs block the H⁺/K⁺ ATPase enzyme in gastric parietal cells → reducing acid secretion.
🔗 Scientific Reference:
📊 Bangladesh Gastric Market Overview (Q4 2025)
📈 Molecule-wise Market Share (Approx.)
- Esomeprazole → 60–70% (Market Leader)
- Omeprazole → 15–20%
- Pantoprazole → 10–15%
- Rabeprazole → 5–10%
🏭 Company Leadership (Q4 2025)
- Square Pharmaceuticals → #1 position
- Beximco Pharmaceuticals → Strong growth
- Incepta Pharmaceuticals → Hospital segment leader
👉 The dominance of Esomeprazole brands is due to:
- Better bioavailability
- Strong physician trust
- Aggressive marketing
🔝 Top 10 Gastric Brands in Bangladesh (2025)
📊 Introduction
The Bangladesh pharmaceutical market continues to show strong growth, with gastric medicines (PPIs) dominating the top-selling drug list. According to IQVIA Q4 2025 data, several gastric brands are ranked among the top 10 highest-selling medicines in Bangladesh, highlighting their massive demand.
This article analyzes the top gastric brands based on real market data, including sales value (Billion BDT) and market share (%).
🔝 Top Gastric Brands from IQVIA Ranking (Q4 2025)
🥇 1. Sergel – #1 Gastric Brand in Bangladesh
- Generic: Esomeprazole
- Company: Healthcare Pharmaceuticals
- Market Value: 6.2 Billion BDT
- Market Share: 2.5%
👉 Key Insight:
Sergel is the highest-selling gastric medicine in Bangladesh, making it the true market leader in the PPI segment.
🥈 2. Seclo – Square Pharmaceuticals
- Generic: Omeprazole
- Market Value: 3.8 Billion BDT
- Market Share: 1.6%
👉 One of the oldest and most trusted brands in Bangladesh with strong nationwide penetration.
🥉 3. Maxpro – Renata Limited
- Generic: Esomeprazole
- Market Value: 3.6 Billion BDT
- Market Share: 1.5%
👉 Rapidly growing Esomeprazole brand with strong physician acceptance.
🏅 4. Pantonix – Incepta Pharmaceuticals
- Generic: Pantoprazole
- Market Value: 3.0 Billion BDT
- Market Share: 1.3%
👉 Hospital-leading PPI brand with strong IV and oral usage.
🏅 5. Exium – Radiant Pharmaceuticals
- Generic: Esomeprazole
- Market Value: 1.7 Billion BDT
- Market Share: 0.7%
👉 Premium segment Esomeprazole brand with stable growth.
📊 Key Market Insight (Q4 2025)
🔬 Molecule Dominance
From the IQVIA ranking:
- Esomeprazole (Sergel, Maxpro, Exium) → Dominating
- Omeprazole (Seclo) → Strong legacy presence
- Pantoprazole (Pantonix) → Hospital segment
👉 Conclusion:
Esomeprazole is the #1 molecule in Bangladesh gastric market
💰 Market Value Comparison (Top Gastric Brands)
| Brand | Value (Billion BDT) | Share (%) |
|---|---|---|
| Sergel | 6.2 | 2.5 |
| Seclo | 3.8 | 1.6 |
| Maxpro | 3.6 | 1.5 |
| Pantonix | 3.0 | 1.3 |
| Exium | 1.7 | 0.7 |
👉 Total (Top 5 Gastric Only): ~18.3 Billion BDT
📈 Why Gastric Medicines Dominate Bangladesh Market?
🔥 1. High GERD & Ulcer Cases
- Food habits (spicy/oily food)
- Irregular lifestyle
🔥 2. OTC Usage
- Easy availability without prescription
🔥 3. NSAID-Induced Gastric Issues
- High use of painkillers → increased gastric problems
🏥 Clinical Comparison (Based on Market Leaders)
| Brand | Molecule | Strength |
|---|---|---|
| Sergel | Esomeprazole | Market leader |
| Seclo | Omeprazole | Legacy trust |
| Maxpro | Esomeprazole | Fast growth |
| Pantonix | Pantoprazole | Hospital use |
⚠️ DGDA / Clinical Guidance
Important Safety Notes:
- Avoid long-term unnecessary use
- Monitor:
- Vitamin B12 deficiency
- Bone health
Recommended Practice:
✔ Use lowest effective dose
✔ Use based on indication (GERD, ulcer)